This is consistent with the emerging picture from cancer genome sequencing studies of remarkably constrained tissue specific patterns of mutations even in pathways that, like the VHL-HIF pathway, have general cellular functions - i.e. somatic mutations that drive cancer must be just right and occur in just the right context for cancer development. The gene discussed is VHL; the disease is cancer.